NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Concert Bio

Concert Bio

Private
LondonHealthcare & Life Scienceshttps://www.concert.bio/

Last Round

Accelerator

Oct 30, 2024

Total Funding Raised

$7.46M

Company Overview

Concert Bio is a biotechnology company that develops microbiome monitoring and optimization tools, including beneficial microbe products, for hydroponic greenhouse growers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

agricultural biotechnologyagritechmicrobial productsbiostimulantsmicrobiome monitoringsustainable farmingcrop healthbioinformaticshydroponicsbiological crop protectionDNA sequencingmicrobial inoculantsagtechprecision agriculturebiological inputs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Concert Bio Comparables

Compare Concert Bio with similar companies based on industry and business-model similarity.

Concert Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ceragen
80%
BioConsortia, Inc.
80%
Boost Biomes
76%

Concert Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 30, 2024
GrantDec 5, 2023
SeedNov 1, 2023
GrantNov 1, 2023
Pre SeedAug 1, 2022

Key People

Founding team and executive leadership

Paul Rutten

Founder And CEO

Founding Team

Lisa Avenell

Chief Operating Officer

Executive Team

Concert Bio Investors

Notable investors and investment history

Concert Bio investors
InvestorRounds
Innovate UKGrant
Nucleus CapitalPre Seed
Ascension VenturesSeed
EQT FoundationAccelerator, Seed
Climate CapitalPre Seed
Ponderosa VenturesPre Seed
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    Operates research greenhouse facilities at the University of Warwick Innovation Campus.

  • Jan 1, 2026

    Launched its first leafy green product, Overture®.

Concert Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Concert Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Concert Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range14
Year Founded2021
Last FundingOct 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.